3860 results for «558»
3860 results
Optimal SCAD treatment
22 May 2025 – From EuroPCR 2025
Navigate the complexities of spontaneous coronary artery dissection (SCAD) treatment through clinical case discussions. This session explores identifying the culprit lesion, recurrent ACS challenges, the conservative versus PCI treatment dilemma, and real-world presentation scenarios emphasizing decision-making in SCAD management.
Which device for which patient: DES, BRS or DCB?
22 May 2025 – From EuroPCR 2025
This session provides comprehensive guidance on selecting the appropriate device—DES, BRS, or DCB—for individual patients and lesions. It examines patient and lesion characteristics, strengths and limitations of each device type, and regional considerations, illustrated by case presentations demonstrating practical device choice and resolution.
PCI in a challenging coronary anatomy
22 May 2025 – From EuroPCR 2025
This session tackles PCI in challenging coronary anatomies, featuring cases with anomalous coronary arteries, complex access routes, and specialized stenting techniques. Learn from experiences managing dual anomalous arteries, navigating to difficult lesions, and applying innovative modified chimney stent methods to restore coronary flow.
Innovative strategies for coronary interventions
22 May 2025 – From EuroPCR 2025
Explore innovative strategies in coronary interventions, including the EPIC26 sirolimus-eluting stent study, use of percutaneous ventricular assist devices in high-risk patients, the SCORE multicenter study on SeQuent SCB, DCB versus DES for ostial left circumflex lesions, and site-specific antithrombotic therapy outcomes from the DESyne BDS Plus...
Combined LAA closure and transcatheter mitral valve repair - LIVE Case
22 May 2025 – From EuroPCR 2025
An 82-year-old male patient with a history of PM (pacemaker) implantation in 2024, and ischaemic cardiomyopathy presented with symptomatic heart failure due to severe secondary mitral regurgitation and impaired LV function (EF 40 %). He also presented with recurrent gastro-intestinal bleeding while on DOAC for atrial...
Emerging indications for TAVI in 2025
22 May 2025 – From EuroPCR 2025
Prepare for emerging TAVI indications anticipated in 2025. This session reviews clinical cases including asymptomatic severe aortic stenosis, moderate aortic stenosis with heart failure, and severe aortic regurgitation. It discusses supporting evidence from clinical trials, evolving transcatheter technologies, and practical treatment approaches for these novel indications.
Redo TAVI - How to treat different TAVI platforms when they fail
22 May 2025 – From EuroPCR 2025
Understand the complexities of redo TAVI procedures with emphasis on planning, valve platform characteristics, and tailored procedural strategies. This session features cases of redo TAVI for failed short-frame and tall-frame valves, alongside discussions on current evidence gaps guiding optimal management.
TAVI in women
22 May 2025 – From EuroPCR 2025
Focus on gender-specific considerations in TAVI with this session. Topics include timely management and referral disparities in women with severe aortic stenosis, early outcomes from the LANDMARK trial with latest-generation valves, insights from NAVULTRA comparing valve types, prosthesis-patient mismatch data, and gender differences in right ventricular...
High thrombus burden in STEMI
22 May 2025 – From EuroPCR 2025
This session addresses the management of high thrombus burden in STEMI patients. It reviews available tools and strategies for thrombus management, presents multiple case-based discussions illustrating treatment decisions, and explores the evolving role of thrombus aspiration in contemporary practice.
Innovations in transcatheter aortic valve devices and techniques
22 May 2025 – From EuroPCR 2025
Explore the latest advancements in transcatheter aortic valve devices and innovative procedural techniques. This session presents initial clinical experiences with new self-expandable valves in small annuli, safety and performance data from the GENESIS-II study on the Hydra valve, and up to 12-month outcomes from the Valvosoft...
Integrating CT coronary angiography into your PCI practice
22 May 2025 – From EuroPCR 2025
Integrate CT coronary angiography into your PCI practice to enhance procedural planning and outcomes. This session covers practical CT-based approaches for guiding catheter selection, lesion analysis, and stenting strategy. Learn how to leverage CT imaging to anticipate plaque preparation needs in calcified lesions and optimize catheterization...
Artificial intelligence in the cathlab
22 May 2025 – From EuroPCR 2025
Delve into the transformative role of artificial intelligence (AI) in the cathlab. This session covers AI applications for vulnerable plaque identification using intracoronary OCT, automated coronary angiogram analysis, rapid AI-based OCT interpretation, AI-enhanced decision-making for PCI optimization, and noninvasive microvascular resistance assessment powered by AI.
Understanding research: insights from a groundbreaking study
22 May 2025 – From EuroPCR 2025
Enhance your understanding of contemporary research in PCI versus CABG with this session. Learn foundational research principles, latest study findings, and how to translate evidence into clinical practice to improve patient communication and outcomes, bridging the gap between research and everyday cardiology care.
Difficult decision-making in left main revascularisation
22 May 2025 – From EuroPCR 2025
Address difficult clinical decisions in left main coronary artery revascularization through this session featuring complex cases. Topics include prioritization in combined left main, aortic valve disease, and low ejection fraction, management of myocardial infarction with severe mitral regurgitation and cardiogenic shock, and unique cases such as...
Mastering mitral valve disease: diagnosis, management, and intervention
31 Jan 2025 – From PCR Imaging Valves Madrid 2025
Dive into this comprehensive session on mitral valve disease, covering key aspects of diagnosis, classification, assessment, management, and patient selection for transcatheter intervention. Gain in-depth knowledge through real-world case studies and multidisciplinary team discussions, equipping you with essential skills to optimize patient care.
Advancing imaging and intervention strategies for mitral valve disease
31 Jan 2025 – From PCR Imaging Valves Madrid 2025
Explore the latest imaging techniques for transcatheter mitral valve interventions, including patient screening, device selection, and strategies for challenging anatomies. Gain insights into TEER and transcatheter mitral valve replacement to optimize patient outcomes.
Optimizing diagnosis and treatment in multivalvular heart disease
01 Feb 2025 – From PCR Imaging Valves Madrid 2025
This session explores the diagnostic challenges and treatment strategies for mixed and multiple valvular heart diseases. Through case scenarios, including aortic stenosis, regurgitation, and combined atrioventricular valve regurgitation, learn how to use imaging modalities to assess severity and determine optimal treatment timing.
Maximising the potential of MitraClip in TEER therapy
08 Feb 2025 – From PCR Tokyo Valves 2025
Explore the latest advancements in TEER therapy with this PCR Tokyo Valves 2025 session dedicated to MitraClip. Through expert-led case discussions, gain a deeper understanding of complex scenarios, including restricted posterior leaflet in functional mitral regurgitation, commissure lesion (A3P3), and MitraClip combined with Amulet.
This session also...
Mastering techniques from basic to complex - TEER for degenerative mitral regurgitation and complex situations
07 Feb 2025 – From PCR Tokyo Valves 2025
Explore the complexities of transcatheter edge-to-edge repair (TEER) for degenerative mitral regurgitation in this PCR Tokyo Valves 2025 session. Gain insights into anatomical challenges, key procedural steps, and expert strategies for managing complex cases. Compare MitraClip and PASCAL for degenerative MR, learn how to handle commissural...
TAVI in small annulus - LIVE case
08 Feb 2025 – From PCR Tokyo Valves 2025
A 79-year-old female with CAD (stenosis in the mid-LAD), asthma, and diabetes presented with symptomatic severe aortic stenosis. Left ventricular function was preserved, with an annulus measuring 355 mm², and the valves were heavily calcified.
A Navitor Vision valve was implanted with predilatation (18 mm balloon) under...
